person · Reporting owner

BRANDT ERIC

Disclosed activity across 7 companies

Tapewire entity: 10671
SEC CIK: 0001190639

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
DENTSPLY SIRONA Inc.XRAY · Entity 4448	Director	April 12, 2024	April 15, 2024
Gen Digital Inc.GEN · Entity 2098	Director	September 09, 2026	September 11, 2026
LAM RESEARCH CORPLRCX · Entity 1467	Director	June 12, 2026	June 15, 2026
MACERICH COMAC · Entity 3712	Director	May 30, 2024	June 04, 2024
Nutanix, Inc.NTNX · Entity 3296	Director	December 12, 2025	December 17, 2025
Option Care Health, Inc.OPCH · Entity 4126	Director	May 20, 2026	May 22, 2026
VERTEX PHARMACEUTICALS INC / MAVRTX · Entity 2875	Director	January 29, 2009	January 30, 2009

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

DENTSPLY SIRONA Inc.

Report date April 12, 2024 · Filed April 15, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	53,372.146	Reported balance After 2024-04-12 transaction · row 2 1 source row Row 2 · 2024-04-12 · Grant · Acquired 72.546 · Balance 53,372.146 F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
Phantom Stock (Directors' Deferred Compensation) DDCSEC Table II · derivative / convertible security	Direct	1,543.4018	Reported balance After 2024-04-12 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2024-04-12 · Grant · Acquired 7.8111 · Balance 1,543.4018 F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. F3: Comprised of phantom stock acquired as a result of accrued dividends.
Common StockSEC Table I · non-derivative	IndirectBy The Brandt Family Trust U/a Dtd 06/09/2006	5,400	Reported balance Holding disclosure · report date 2024-04-12 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 5,400

Filing footnotes · ownership attribution and instrument terms

F1: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

F2: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director.

F3: Comprised of phantom stock acquired as a result of accrued dividends.

Gen Digital Inc.

Report date September 09, 2026 · Filed September 11, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	9,072	Ending reported balance After 2026-09-09 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2026-09-09 · Grant · Acquired 9,072 · Balance 17,894 F1: Annual non-employee director equity award. The RSUs will vest 100% on the earlier of September 9, 2027, or the next annual meeting, and subject to service through the respective vesting date. Row 2 · 2026-09-09 · Gift · Disposed 8,822 · Balance 9,072 F2: Stock transfer to family trust over which the reporting person has voting power.
Common StockSEC Table I · non-derivative	IndirectThe Brandt Family Trust	78,506	Reported balance After 2026-09-09 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2026-09-09 · Gift · Acquired 8,822 · Balance 78,506

Filing footnotes · ownership attribution and instrument terms

F1: Annual non-employee director equity award. The RSUs will vest 100% on the earlier of September 9, 2027, or the next annual meeting, and subject to service through the respective vesting date.

F2: Stock transfer to family trust over which the reporting person has voting power.

LAM RESEARCH CORP

Report date June 12, 2026 · Filed June 15, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	144,705	Last balance in matching sequence After 2026-06-12 transaction · row 17 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 17 source rows Row 1 · 2026-06-12 · Sale · Disposed 300 · Balance 198,905 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $355.39 to $356.02, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 2 · 2026-06-12 · Sale · Disposed 1,393 · Balance 197,512 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $356.685 to $357.67, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 3 · 2026-06-12 · Sale · Disposed 1,100 · Balance 196,412 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F5: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $357.68 to $358.35, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 4 · 2026-06-12 · Sale · Disposed 3,828 · Balance 192,584 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F6: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $358.73 to $359.54, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 5 · 2026-06-12 · Sale · Disposed 1,906 · Balance 190,678 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F7: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $359.84 to $360.79, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 6 · 2026-06-12 · Sale · Disposed 819 · Balance 189,859 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F8: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $360.85 to $361.83, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 7 · 2026-06-12 · Sale · Disposed 2,708 · Balance 187,151 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F9: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $361.87 to $362.82, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 8 · 2026-06-12 · Sale · Disposed 2,345 · Balance 184,806 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F10: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $363.77, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 9 · 2026-06-12 · Sale · Disposed 2,300 · Balance 182,506 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F11: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $364.85, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 10 · 2026-06-12 · Sale · Disposed 1,200 · Balance 181,306 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F12: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $364.98 to $365.67, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 11 · 2026-06-12 · Sale · Disposed 5,803 · Balance 175,503 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F13: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $366.56 to $367.55, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 12 · 2026-06-12 · Sale · Disposed 4,030 · Balance 171,473 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F14: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $367.62 to $368.49, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 13 · 2026-06-12 · Sale · Disposed 4,198 · Balance 167,275 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F15: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.70 to $369.64, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 14 · 2026-06-12 · Sale · Disposed 5,037 · Balance 162,238 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F16: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $369.70 to $370.69, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 15 · 2026-06-12 · Sale · Disposed 8,233 · Balance 154,005 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F17: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $370.70 to $371.59, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 16 · 2026-06-12 · Sale · Disposed 7,700 · Balance 146,305 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F18: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $371.77 to $372.76, inclusive F3: The amount reported includes shares subject to unvested restricted stock units. Row 17 · 2026-06-12 · Sale · Disposed 1,600 · Balance 144,705 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F19: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $372.79 to $373.36, inclusive F3: The amount reported includes shares subject to unvested restricted stock units.

Filing footnotes · ownership attribution and instrument terms

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $355.39 to $356.02, inclusive

F3: The amount reported includes shares subject to unvested restricted stock units.

F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $356.685 to $357.67, inclusive

F5: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $357.68 to $358.35, inclusive

F6: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $358.73 to $359.54, inclusive

F7: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $359.84 to $360.79, inclusive

F8: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $360.85 to $361.83, inclusive

F9: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $361.87 to $362.82, inclusive

F10: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $363.77, inclusive

F11: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $364.85, inclusive

F12: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $364.98 to $365.67, inclusive

F13: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $366.56 to $367.55, inclusive

F14: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $367.62 to $368.49, inclusive

F15: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.70 to $369.64, inclusive

F16: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $369.70 to $370.69, inclusive

F17: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $370.70 to $371.59, inclusive

F18: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $371.77 to $372.76, inclusive

F19: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $372.79 to $373.36, inclusive

MACERICH CO

Report date May 30, 2024 · Filed June 04, 2024 · Amendment

Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	62,978	Reported balance Holding disclosure · report date 2024-05-30 · row 1 Amendment: may correct only part of an earlier disclosure. 1 source row Row 1 · Balance 62,978

Nutanix, Inc.

Report date December 12, 2025 · Filed December 17, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	6,698	Reported balance After 2025-12-12 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2025-12-12 · Grant · Acquired 4,588 · Balance 6,698 F1: Reflects shares that the Reporting Person will receive upon the settlement of restricted stock units ("RSUs"), which will vest in full on the earlier of (i) the day prior to the next annual meeting of the Issuer's shareholders held after the date of grant or (ii) the one-year anniversary of the date of grant, in each case, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock. F2: The amount reported includes 4,588 unvested RSUs, which are issuable into shares of the Issuer's Class A common stock upon vesting.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects shares that the Reporting Person will receive upon the settlement of restricted stock units ("RSUs"), which will vest in full on the earlier of (i) the day prior to the next annual meeting of the Issuer's shareholders held after the date of grant or (ii) the one-year anniversary of the date of grant, in each case, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of Issuer's Class A common stock.

F2: The amount reported includes 4,588 unvested RSUs, which are issuable into shares of the Issuer's Class A common stock upon vesting.

Option Care Health, Inc.

Report date May 20, 2026 · Filed May 22, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	21,999	Ending reported balance After 2026-05-20 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2026-05-20 · Grant · Acquired 8,997 · Balance 19,356 F1: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026. Row 2 · 2026-05-20 · Grant · Acquired 2,643 · Balance 21,999 F2: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.

F2: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026.

VERTEX PHARMACEUTICALS INC / MA

Report date January 29, 2009 · Filed January 30, 2009

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Ending reported balance After 2009-01-29 transaction · row 3 3 source rows · reconciled sequence Row 1 · 2009-01-29 · Exercise / conversion · Acquired 20,000 · Balance 20,000 Row 2 · 2009-01-29 · Exercise / conversion · Acquired 7,500 · Balance 27,500 Row 3 · 2009-01-29 · Sale · Disposed 27,500 · Balance 0 F1: Transaction made pursuant to Mr. Brandt's company approved trading plan under Rule 10b5-1.
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $13.22 · Expires 2013-05-20	Direct	Reported balance After 2009-01-29 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2009-01-29 · Exercise / conversion · Disposed 20,000 · Balance 0 F2: Fully vested.
Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $9.09 · Expires 2015-05-31	Direct	Reported balance After 2009-01-29 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2009-01-29 · Exercise / conversion · Disposed 7,500 · Balance 0 F2: Fully vested.

Filing footnotes · ownership attribution and instrument terms

F1: Transaction made pursuant to Mr. Brandt's company approved trading plan under Rule 10b5-1.

F2: Fully vested.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
September 09, 2026 Filed Sep 11, 2026 21:12 UTC	Gen Digital Inc. GEN · Entity 2098	GiftCommon Stock	8,822	$0.00	$0.00	Disclosure SEC source: 0000849399-26-000064 · wk-form4_1789161144.xml · nonDerivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · The Brandt Family Trust Disclosed balance after: 78,506 Read SEC document
September 09, 2026 Filed Sep 11, 2026 21:12 UTC	Gen Digital Inc. GEN · Entity 2098	GiftCommon Stock	8,822	$0.00	$0.00	Disclosure SEC source: 0000849399-26-000064 · wk-form4_1789161144.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,072 F2 · shares: Stock transfer to family trust over which the reporting person has voting power. Read SEC document
September 09, 2026 Filed Sep 11, 2026 21:12 UTC	Gen Digital Inc. GEN · Entity 2098	GrantCommon Stock	9,072	$0.00	$0.00	Disclosure SEC source: 0000849399-26-000064 · wk-form4_1789161144.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,894 F1 · shares: Annual non-employee director equity award. The RSUs will vest 100% on the earlier of September 9, 2027, or the next annual meeting, and subject to service through the respective vesting date. Read SEC document
June 12, 2026 Filed Jun 15, 2026 23:33 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	1,600	$373.09	$596,944.00	Disclosure SEC source: 0001190639-26-000006 · wk-form4_1781566408.xml · nonDerivative · entry 17 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 144,705 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F19 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $372.79 to $373.36, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 12, 2026 Filed Jun 15, 2026 23:33 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	7,700	$372.23	$2,866,171.00	Disclosure SEC source: 0001190639-26-000006 · wk-form4_1781566408.xml · nonDerivative · entry 16 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,305 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F18 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $371.77 to $372.76, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 12, 2026 Filed Jun 15, 2026 23:33 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	8,233	$371.17	$3,055,842.61	Disclosure SEC source: 0001190639-26-000006 · wk-form4_1781566408.xml · nonDerivative · entry 15 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 154,005 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F17 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $370.70 to $371.59, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 12, 2026 Filed Jun 15, 2026 23:33 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	5,037	$370.27	$1,865,049.99	Disclosure SEC source: 0001190639-26-000006 · wk-form4_1781566408.xml · nonDerivative · entry 14 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 162,238 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F16 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $369.70 to $370.69, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 12, 2026 Filed Jun 15, 2026 23:33 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	4,198	$369.16	$1,549,733.68	Disclosure SEC source: 0001190639-26-000006 · wk-form4_1781566408.xml · nonDerivative · entry 13 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 167,275 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F15 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $368.70 to $369.64, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 12, 2026 Filed Jun 15, 2026 23:33 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	4,030	$368.03	$1,483,160.90	Disclosure SEC source: 0001190639-26-000006 · wk-form4_1781566408.xml · nonDerivative · entry 12 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 171,473 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F14 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $367.62 to $368.49, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 12, 2026 Filed Jun 15, 2026 23:33 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	5,803	$367.01	$2,129,759.03	Disclosure SEC source: 0001190639-26-000006 · wk-form4_1781566408.xml · nonDerivative · entry 11 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 175,503 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F13 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $366.56 to $367.55, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 12, 2026 Filed Jun 15, 2026 23:33 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	1,200	$365.16	$438,192.00	Disclosure SEC source: 0001190639-26-000006 · wk-form4_1781566408.xml · nonDerivative · entry 10 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 181,306 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F12 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $364.98 to $365.67, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 12, 2026 Filed Jun 15, 2026 23:33 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	2,300	$364.41	$838,143.00	Disclosure SEC source: 0001190639-26-000006 · wk-form4_1781566408.xml · nonDerivative · entry 9 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 182,506 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F11 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $364.85, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 12, 2026 Filed Jun 15, 2026 23:33 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	2,345	$363.33	$852,008.85	Disclosure SEC source: 0001190639-26-000006 · wk-form4_1781566408.xml · nonDerivative · entry 8 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 184,806 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F10 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.92 to $363.77, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 12, 2026 Filed Jun 15, 2026 23:33 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	2,708	$362.40	$981,379.20	Disclosure SEC source: 0001190639-26-000006 · wk-form4_1781566408.xml · nonDerivative · entry 7 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 187,151 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F9 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $361.87 to $362.82, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 12, 2026 Filed Jun 15, 2026 23:33 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	819	$361.21	$295,830.99	Disclosure SEC source: 0001190639-26-000006 · wk-form4_1781566408.xml · nonDerivative · entry 6 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 189,859 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F8 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $360.85 to $361.83, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 12, 2026 Filed Jun 15, 2026 23:33 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	1,906	$360.15	$686,445.90	Disclosure SEC source: 0001190639-26-000006 · wk-form4_1781566408.xml · nonDerivative · entry 5 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 190,678 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F7 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $359.84 to $360.79, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 12, 2026 Filed Jun 15, 2026 23:33 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	3,828	$359.08	$1,374,558.24	Disclosure SEC source: 0001190639-26-000006 · wk-form4_1781566408.xml · nonDerivative · entry 4 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 192,584 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F6 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $358.73 to $359.54, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 12, 2026 Filed Jun 15, 2026 23:33 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	1,100	$357.98	$393,778.00	Disclosure SEC source: 0001190639-26-000006 · wk-form4_1781566408.xml · nonDerivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 196,412 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F5 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $357.68 to $358.35, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 12, 2026 Filed Jun 15, 2026 23:33 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	1,393	$357.24	$497,635.32	Disclosure SEC source: 0001190639-26-000006 · wk-form4_1781566408.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 197,512 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $356.685 to $357.67, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 12, 2026 Filed Jun 15, 2026 23:33 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	300	$355.71	$106,713.00	Disclosure SEC source: 0001190639-26-000006 · wk-form4_1781566408.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 198,905 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $355.39 to $356.02, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	642	$364.00	$233,688.00	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 26 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 199,205 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F27 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $363.765 to $364.37, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	5,717	$362.95	$2,074,985.15	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 25 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 199,847 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F26 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $362.58 to $363.57, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	2,604	$362.20	$943,168.80	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 24 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 205,564 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F25 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $361.595 to $362.550, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	1,756	$361.05	$634,003.80	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 23 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 208,168 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F24 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $360.60 to $361.54, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	664	$360.24	$239,199.36	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 22 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 209,924 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F23 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $359.819 to $360.59, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	780	$359.24	$280,207.20	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 21 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 210,588 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F22 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $358.79 to $359.735, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	1,880	$358.22	$673,453.60	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 20 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 211,368 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F21 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $357.762 to $358.70, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	1,455	$357.06	$519,522.30	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 19 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 213,248 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F20 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $356.759 to $357.703, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	1,653	$356.27	$588,914.31	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 18 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,703 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F19 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $355.75 to $356.709, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	1,331	$355.50	$473,170.50	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 17 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 216,356 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F18 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $354.805 to $355.746, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	1,461	$354.08	$517,310.88	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 16 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,687 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F17 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $353.818 to $354.743, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	1,172	$353.52	$414,325.44	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 15 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 219,148 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F16 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $352.824 to $353.805, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	36	$350.77	$12,627.72	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 14 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,320 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	1,517	$349.79	$530,631.43	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 13 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,356 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F15 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $349.409 to $350.260, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	4,334	$348.73	$1,511,395.82	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 12 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 221,873 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F14 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $348.391 to $349.351, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	6,592	$347.86	$2,293,093.12	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 11 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 226,207 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F13 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $347.383 to $348.355, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	3,442	$346.79	$1,193,651.18	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 10 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 232,799 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F12 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $346.383 to $347.359, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	2,832	$345.84	$979,418.88	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 9 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 236,241 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F11 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $345.386 to $346.336, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	3,208	$344.92	$1,106,503.36	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 8 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 239,073 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F10 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $344.396 to $345.348, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	1,481	$343.96	$509,404.76	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 7 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 242,281 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F9 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $343.40 to $344.377, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	3,644	$342.91	$1,249,564.04	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 6 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 243,762 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F8 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $342.415 to $343.39, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	1,070	$341.81	$365,736.70	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 5 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 247,406 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F7 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $341.418 to $342.202, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	1,277	$340.68	$435,048.36	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 4 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 248,476 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F6 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $340.278 to $341.249, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	1,895	$339.75	$643,826.25	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 3 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 249,753 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F5 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $339.23 to $340.20, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	1,083	$338.62	$366,725.46	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 251,648 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $338.19 to $339.15, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
June 11, 2026 Filed Jun 15, 2026 16:27 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	974	$337.56	$328,783.44	Disclosure SEC source: 0001190639-26-000004 · wk-form4_1781540828.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 252,731 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $337.00 to $337.97, inclusive F3 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
May 20, 2026 Filed May 22, 2026 22:05 UTC	Option Care Health, Inc. OPCH · Entity 4126	GrantCommon Stock	2,643	$22.23	$58,753.89	Disclosure SEC source: 0001437749-26-018296 · rdgdoc.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,999 F2 · shares: The reporting person received restricted stock units on May 20, 2026 in lieu of cash retainer payments, which will vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 20, 2026. Read SEC document
May 20, 2026 Filed May 22, 2026 22:05 UTC	Option Care Health, Inc. OPCH · Entity 4126	GrantCommon Stock	8,997	$0.00	$0.00	Disclosure SEC source: 0001437749-26-018296 · rdgdoc.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,356 F1 · shares: The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026. Read SEC document
February 06, 2026 Filed Feb 9, 2026 19:00 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	18,000	$230.00	$4,140,000.00	Disclosure SEC source: 0001190639-26-000002 · wk-form4_1770663608.xml · nonDerivative · entry 2 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253,705 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document
February 06, 2026 Filed Feb 9, 2026 19:00 UTC	LAM RESEARCH CORP LRCX · Entity 1467	SaleCommon Stock	17,000	$220.95	$3,756,150.00	Disclosure SEC source: 0001190639-26-000002 · wk-form4_1770663608.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 271,705 F1 · balance_after: The amount reported includes shares subject to unvested restricted stock units. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.